Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly population

J Flamaing1, J Verhaegen, W E Peetermans

  • 1Department of Geriatric Medicine, Department of Microbiology, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium.

Insights

Invasive Streptococcus pneumoniae bloodstream infections (bacteraemia) are common in children and the elderly. Antibiotic resistance is rising in both groups, with children showing higher erythromycin resistance, and vaccine strategies need to consider these trends.

Area of Science:

  • * Infectious Diseases
  • * Microbiology
  • * Pediatrics and Geriatrics

Background:

  • * Streptococcus pneumoniae is a leading cause of bacterial infections worldwide.
  • * Bacteraemia, a serious bloodstream infection, requires understanding of epidemiological trends and resistance patterns.
  • * Vulnerable populations, including young children and the elderly, are at higher risk for invasive pneumococcal disease.

Purpose of the Study:

  • * To compare the characteristics of Streptococcus pneumoniae bacteraemia in children (0-4 years) and the elderly (>=60 years).
  • * To analyze trends in antibiotic resistance and serotype distribution over a 7-year period (1994-2000).
  • * To evaluate the potential impact of current and future pneumococcal vaccines in these age groups.

Main Methods:

  • * Retrospective analysis of 5837 blood isolates of invasive Streptococcus pneumoniae.
  • * Comparison of data from children (n=843) and the elderly (n=3144) from 1994-2000.
  • * Assessment of penicillin and erythromycin resistance, serogroup and serotype (SGTs) distribution, and vaccine coverage.

Main Results:

  • * Penicillin resistance increased significantly in both children (8.2% to 18.9%) and the elderly (5.1% to 16.35%).
  • * Erythromycin resistance was higher in children (44.7%) than the elderly (25.7%) and increased in the elderly (18.6% to 33.65%).
  • * The elderly had a broader range of SGTs (36) compared to children (26), with distinct prevalent SGTs in each group. Conjugate vaccines showed higher coverage in children, while the 23-valent vaccine offered broad coverage in the elderly.

Conclusions:

  • * Rising antibiotic resistance in Streptococcus pneumoniae necessitates ongoing surveillance and updated treatment guidelines.
  • * Distinct serotype prevalence in children and the elderly highlights the need for age-specific vaccination strategies.
  • * A combined vaccination approach, utilizing both conjugate and polysaccharide vaccines, may be optimal for comprehensive protection in the elderly.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...